ARASENS Trial: Should darolutamide now be added to androgen-deprivation therapy and docetaxel in patients with metastatic, hormone-sensitive prostate cancer?

INDIAN JOURNAL OF UROLOGY(2022)

引用 1|浏览0
暂无评分
关键词
prostate cancer,docetaxel,androgen-deprivation,hormone-sensitive
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要